Loading...
Immuron Limited
IMC.AX•ASX
Healthcare
Biotechnology
A$0.06
A$-0.00(-1.56%)
Immuron Limited (IMC.AX) Financial Performance & Income Statement Overview
Review Immuron Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
171.67%
↑ 171.67%
Operating Income Growth
3.32%
↑ 3.32%
Net Income Growth
-83.20%
↓ 83.20%
Operating Cash Flow Growth
-123.42%
↓ 123.42%
Operating Margin
-96.61%
↓ 96.61%
Gross Margin
67.47%
↑ 67.47%
Net Profit Margin
-112.40%
↓ 112.40%
ROE
-63.80%
↓ 63.80%
ROIC
-60.53%
↓ 60.53%
Immuron Limited (IMC.AX) Income Statement & Financial Overview
Review Immuron Limited's (IMC.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $2.55M | $2.36M | $1.22M | $583646.00 |
| Cost of Revenue | $790836.00 | $775232.00 | $339832.00 | $155726.00 |
| Gross Profit | $1.76M | $1.58M | $881227.00 | $427920.00 |
| Gross Profit Ratio | $0.69 | $0.67 | $0.72 | $0.73 |
| R&D Expenses | $2.72M | $2.65M | $1.07M | $1.52M |
| SG&A Expenses | $3.90M | $2.68M | $2.83M | $2.32M |
| Operating Expenses | $5.54M | $5.34M | $3.47M | $3.84M |
| Total Costs & Expenses | $6.33M | $6.11M | $3.81M | $4.00M |
| Interest Income | $174248.00 | $153508.00 | $62251.00 | $54072.00 |
| Interest Expense | $3569.00 | $4007.00 | $5151.00 | $4501.00 |
| Depreciation & Amortization | $2248.00 | $3667.00 | $5000.00 | $2334.00 |
| EBITDA | -$3.36M | -$1.85M | -$1.54M | -$1.87M |
| EBITDA Ratio | -$1.32 | -$0.79 | -$1.26 | -$3.20 |
| Operating Income | -$3.78M | -$3.75M | -$2.59M | -$3.41M |
| Operating Income Ratio | -$1.48 | -$1.59 | -$2.12 | -$5.85 |
| Other Income/Expenses (Net) | -$1.08M | $1.66M | -$206628.00 | -$79578.00 |
| Income Before Tax | -$4.86M | -$2.09M | -$1.84M | -$2.02M |
| Income Before Tax Ratio | -$1.91 | -$0.89 | -$1.51 | -$3.45 |
| Income Tax Expense | -$545372.00 | -$219609.00 | -$263728.00 | -$129149.00 |
| Net Income | -$4.86M | -$2.07M | -$1.81M | -$1.98M |
| Net Income Ratio | -$1.91 | -$0.88 | -$1.48 | -$3.39 |
| EPS | -$0.02 | -$0.009 | -$0.008 | -$0.009 |
| Diluted EPS | -$0.02 | -$0.009 | -$0.008 | -$0.009 |
| Weighted Avg Shares Outstanding | $227.93M | $227.80M | $227.80M | $227.80M |
| Weighted Avg Shares Outstanding (Diluted) | $227.92M | $227.80M | $227.80M | $227.80M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan